| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $2,847,982 ) |
| 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155095 | Airway Structural Cells and Corticosteroid Resistance in Asthma | 000 | 5 | NIH | 12/11/2024 | $408,885 |
| 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL135103 | Radiotracer-Based Imaging for Quantitative Assessment of Skeletal Muscle Perfusion in Peripheral Artery Disease | 000 | 7 | NIH | 12/27/2024 | $595,067 |
| 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MD016064 | Racial/ethnic and geographic differences in pediatric tonsillectomy use: a multilevel investigation | 000 | 4 | NIH | 1/9/2025 | $328,941 |
| 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155095 | Airway Structural Cells and Corticosteroid Resistance in Asthma | 001 | 5 | NIH | 12/12/2024 | $62,586 |
| 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 00 | 6 | CMS | 12/16/2024 | $1,930,464 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 000 | 4 | NIH | 1/1/2025 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL163065 | A Preclinical Study Evaluating and Comparing the Efficacy of Tissue Engineered Vascular Grafts to Polytetrafluoroethylene Grafts | 000 | 3 | NIH | 12/21/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL148693 | A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2) | 000 | 4 | NIH | 12/19/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL161338 | 1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL) | 000 | 3 | NIH | 10/29/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS133037 | Quality Improvement in time to Treatment of Status Epilepticus (QuITT-SE) | 000 | 2 | NIH | 11/15/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DK100866 | CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | 001 | 12 | NIH | 11/4/2024 | $156,580 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating NOTCH signaling in myocardial-endocardial interactions in cardiac development and disease | 000 | 4 | NIH | 11/29/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL165124 | The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | 000 | 2 | NIH | 12/4/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H3348997 | EMSC Partnership Grants | 02 | 2 | HRSA | 1/2/2025 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U1V46321 | Catalysts for Infant Health Equity | 01 | 3 | HRSA | 12/20/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H79SM084968 | Expanding Access to Peritrauma and Trauma Treatment for Families in Central Ohio | 000 | 4 | SAMHSA | 12/16/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 05 | 5 | CMS | 11/6/2024 | $0 |
| 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4B15471 | Poison Control Stabilization and Enhancement Program | 01 | 16 | HRSA | 11/22/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AR073908 | Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders | 000 | 5 | NIH | 10/10/2024 | -$10,992 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08DK122119 | Urothelial IL-6 Signaling in the Host Defense Against Urinary Tract Infections | 000 | 5 | NIH | 10/17/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08DK122119 | Urothelial IL-6 Signaling in the Host Defense Against Urinary Tract Infections | 001 | 5 | NIH | 10/17/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DK100866 | CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | 000 | 11 | NIH | 11/4/2024 | -$156,580 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL145032 | Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes | 000 | 5 | NIH | 10/30/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Oncolytic virus bispecific gene delivery for high grade gliomas | 006 | 1 | NIH | 12/4/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Oncolytic virus bispecific gene delivery for high grade gliomas | 005 | 1 | NIH | 12/3/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R35GM131875 | Molecular Analysis of primary cilia proteins in human development | 000 | 6 | NIH | 11/22/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21HD110784 | Evaluating the feasibility of an innovative point-of-care screening tool for detection of infant motor delay within the newborn period | 000 | 1 | NIH | 12/3/2024 | $0 |
| 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U3N45413 | Health and Public Safety Workforce Resiliency Training Program | 03 | 2 | HRSA | 1/6/2025 | $0 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MH125905 | Effects of parental history of suicidal behavior on middle/late childhood: Longitudinal assessment of early markers of suicide risk | 000 | 1 | NIH | 1/10/2025 | -$439,897 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD091347 | Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool | 000 | 5 | NIH | 12/15/2024 | -$5,529 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R33AT009632 | Fatty acid supplements alter biological signatures in children with Autism Spectrum Disorder | 001 | 5 | NIH | 1/8/2025 | $1 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R33AT009632 | Fatty acid supplements alter biological signatures in children with Autism Spectrum Disorder | 000 | 5 | NIH | 12/23/2024 | -$9,123 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21HD106252 | Transcranial Doppler Ultrasonography Clinical and Research Centers of Excellence in Sub-Saharan Africa | 000 | 2 | NIH | 12/15/2024 | -$7,451 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AR079774 | Chromatin remodeling gene therapy for FSHD using split-vector AAV SMCHD1 vectors | 000 | 2 | NIH | 11/4/2024 | $0 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Oncolytic virus bispecific gene delivery for high grade gliomas | 001 | 1 | NIH | 11/8/2024 | $0 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Oncolytic virus bispecific gene delivery for high grade gliomas | 004 | 1 | NIH | 11/12/2024 | $0 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AI164077 | Tryptophan metabolism in Haemophilus persistence and formation of intracellular communities | 000 | 2 | NIH | 11/25/2024 | -$1,188 |
| 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | CE147208 | Community Project Funding/Congressionally Directed Spending - Construction | 06 | 1 | HRSA | 10/3/2024 | $0 |
| 2025 | 2021 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01AI131386 | High Precision System Analysis of Infant Immune Responses | 000 | 5 | NIH | 1/8/2025 | -$3,781 |
| 2025 | 2021 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Oncolytic virus bispecific gene delivery for high grade gliomas | 000 | 1 | NIH | 11/8/2024 | $0 |
| 2025 | 2020 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Oncolytic virus bispecific gene delivery for high grade gliomas | 003 | 1 | NIH | 11/11/2024 | $0 |
| 2025 | 2019 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Oncolytic virus bispecific gene delivery for high grade gliomas | 002 | 1 | NIH | 11/11/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $73,384,386 ) (Continued on the next page) |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H79SM084968 | Expanding Access to Peritrauma and Trauma Treatment for Families in Central Ohio | 001 | 4 | SAMHSA | 7/1/2024 | $400,000 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F31HL176054 | Elucidating the cellular and molecular basis of LYST-mediated TEVG stenosis | 000 | 1 | NIH | 8/16/2024 | $44,667 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | T32CA269052 | Training Program in Basic and Translational Pediatric Oncology Research | 001 | 3 | NIH | 6/14/2024 | $287,283 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative-Eliminating Racial/Ethnic Disparities | 02 | 1 | HRSA | 8/28/2024 | $0 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative-Eliminating Racial/Ethnic Disparities | 01 | 1 | HRSA | 6/6/2024 | $0 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative-Eliminating Racial/Ethnic Disparities | 00 | 1 | HRSA | 4/29/2024 | $880,277 |
|